Genetic Susceptibility to Diclofenac-Induced Hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 Genotypes

This publication has 45 references indexed in Scilit:

• Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period
  Gastroenterology, 2005
• Outcome and prognostic markers in severe drug‐induced liver disease†
  Hepatology, 2005
• Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden
  Scandinavian Journal of Gastroenterology, 2005
• Acute and clinically relevant drug‐induced liver injury: a population based case‐control study
  British Journal of Clinical Pharmacology, 2004
• Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity
  Toxicology and Applied Pharmacology, 2003
• The Metabolism of Diclofenac - Enzymology and Toxicology Perspectives
  Current Drug Metabolism, 2003
• Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs
  Journal of Hepatology, 2002
• Comparison of Two Clinical Scales for Causality Assessment in Hepatotoxicity
  Hepatology, 2001
• Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis
  Pharmacogenetics, 2000
• Idiosyncratic Liver Toxicity of Nonsteroidal Antiinflammatory Drugs: Molecular Mechanisms and Pathology
  Critical Reviews in Toxicology, 1995